Related Experiment Video
Updated: Jun 17, 2026
08:24
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Methods and models in neurodegenerative and systemic protein aggregation diseases
Ann-Christin Brorsson1, Janet R Kumita, Ian MacLeod
1Molecular Biotechnology/IFM, Linkoping University, SE-581 83, Linkoping, Sweden.
Frontiers in Bioscience (Landmark Edition)
|December 29, 2009
Summary
Protein misfolding causes diseases like dementia and diabetes. This review explores experimental methods to understand the origins of Alzheimer's disease, lysozyme amyloidosis, and serpinopathies.
Area of Science:
- Biochemistry
- Neuroscience
- Pathology
Background:
- Protein misfolding and aggregation are central to prevalent human diseases, including neurodegenerative disorders and diabetes.
- Investigating the pathogenesis of these disorders is crucial for developing effective treatments.
Purpose of the Study:
- To review current experimental strategies for investigating the pathogenesis of three key protein misfolding disorders: Alzheimer's disease, lysozyme amyloidosis, and serpinopathies.
- To correlate in vitro findings with in vivo and animal model data.
Main Methods:
- Characterization of amyloid beta (Abeta) aggregation properties in vitro.
- In vitro and in vivo studies of mutational variants of lysozyme.
- Exploration of experimental paradigms for studying serpinopathies, including neuroserpin polymerization.
Main Results:
- Methods for characterizing Abeta aggregation and correlating them with animal models are discussed.
- In vitro and in vivo experiments offer insights into the origins of lysozyme amyloidosis.
- Varied approaches are employed to study serpinopathies and neuroserpin polymerization.
Conclusions:
- Experimental strategies are vital for understanding the pathogenesis of protein misfolding disorders.
- Correlating in vitro, in vivo, and animal model data provides a comprehensive view of disease mechanisms.
- Further research into these disorders may lead to novel therapeutic interventions.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...